MedPath

The effect of Basil on vaginal atrophy

Phase 2
Recruiting
Conditions
Vaginal atrophy.
Postmenopausal atrophic vaginitis
N95.2
Registration Number
IRCT20240311061257N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Being Iranian and residing in Rasht
Satisfaction with participating in the study
Body mass index less than 30
Reading and writing literacy
Married and having had sexual activity in the past 6 months
Natural menopause
Aged 45-60 years
Normal pap smear
Diagnosis of vaginal atrophy

Exclusion Criteria

Using phytoestrogens one month before the start of the study
Hormone therapy in the past 6 months before the start of the study
Abnormal vaginal bleeding
Specific medical conditions
Use of specific medications
Vaginal infections
History of cancer and estrogen-related diseases
History of severe anxiety and depression
Sensitivity to basil
Visit due to complaints of vaginal atrophy and request for treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mental symptoms of vaginal atrophy. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: Vaginal assessment scale.;Vaginal PH. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: PH-indicator strips.;Vaginal maturation index. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: Pathological examination.;Vaginal maturation value. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: Pathological examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath